Skip to main content
Premium Trial:

Request an Annual Quote

ABI s Decision to License Affy s Array IP Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Dec. 27 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 23.

 

1. ABI Licenses Affy Microarray Patents for Gene Expression Analysis (from Dec. 22)

2. Sequencing DNA of 27,000-Year-Old Woolly Mammoth, Researchers Point to New Field of 'Paleogenomics'  (from Dec. 20)

3. 454 Life Sciences Enters Research Collaboration with Broad Institute (from Dec. 19)

4. 454 and Solexa Pursued by Pack of Next-Gen Sequencing Shops; Competition to Heat up in 2006 (from Dec. 19)

5. Third Wave's ex-CEO Receives Severance; New VP at Orchid Cellmark; Others (from Dec. 21)

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more